Please select the option that best describes you:

How would you proceed for a patient with metastatic gastric-type adenocarcinoma, with vaginal and inguinofemoral disease only, who experiences complete response to her vaginal tumor but residual inguinal disease?  

History of CDH1 mutation and prophylactic gastrectomy in 2017 - no other primary site found beyond vagina at diagnosis.

Vaginal tumor completely responded to FLOT regimen but right inguinal nodes remained enlarged.



Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at Comprehensive Cancer Centers of Nevada
Would maybe consider vaginal HDR boost to consolid...
Sign in or Register to read more

Answer from: Radiation Oncologist at Community Practice
Sign in or Register to read more